secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2026-08-06T20:13:01+00:00
Accession:  0001213900-26-086150
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies settles $10M Leonite note for $1.9M cash + 500k shares; issues $2.2M bridge note
--------------------------------------------------------------------------------

- On July 31, 2026, OS Therapies agreed to pay Leonite $1.9M cash and issue 500,000 shares to fully satisfy the $10M secured convertible note (only $1.6M drawn).
- The settlement cancels the warrant to purchase 1.75M shares at $2.85 and 275,000 commitment shares; all security interests are released.
- To fund the settlement, on Aug 2, 2026, the company issued a $2.2M bridge convertible note (purchase price $2.19M) to an accredited investor, maturing Sept 1, 2026.
- The bridge note automatically converts into a future private offering of up to $10M; proceeds used for settlement and working capital.
- Settlement expected to close by Aug 7, 2026; shares to be issued under effective S-3 registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026086150/0001213900-26-086150-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026086150/ea0300848-8k_ostherapies.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-086150

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer